Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 235

1.

The OPTIMIZE randomized trial to assess safety and efficacy of the Svelte IDS and RX Sirolimus-eluting coronary stent Systems for the Treatment of atherosclerotic lesions: Trial design and rationale.

Mauri L, Doros G, Rao SV, Cohen DJ, Yakubov S, Lasala J, Wong SC, Zidar J, Kereiakes DJ.

Am Heart J. 2019 Jul 13;216:82-90. doi: 10.1016/j.ahj.2019.07.003. [Epub ahead of print]

PMID:
31415994
2.

Factors Associated with Wound Complications after Open Femoral Artery Exposure for Elective Endovascular Abdominal Aortic Aneurysm Repair.

Trinidad B, Rybin D, Doros G, Eslami M, Tan TW.

Int J Angiol. 2019 Jun;28(2):124-129. doi: 10.1055/s-0039-1683898. Epub 2019 Mar 28.

PMID:
31384110
3.

A Novel 3q29 Deletion in Association With Developmental Delay and Heart Malformation-Case Report With Literature Review.

Chirita Emandi A, Dobrescu AI, Doros G, Hyon C, Miclea D, Popoiu C, Puiu M, Arghirescu S.

Front Pediatr. 2019 Jul 8;7:270. doi: 10.3389/fped.2019.00270. eCollection 2019.

4.

Prevalence and prognostic value of D-dimer elevation in patients with AL amyloidosis.

Pudusseri A, Sanchorawala V, Sloan JM, Bever KM, Doros G, Kataria S, Sarosiek S.

Am J Hematol. 2019 Jul 11. doi: 10.1002/ajh.25576. [Epub ahead of print]

PMID:
31292986
5.

Heart failure with mid-range ejection fraction: characterization of patients from the PINNACLE Registry®.

Ibrahim NE, Song Y, Cannon CP, Doros G, Russo P, Ponirakis A, Alexanian C, Januzzi JL Jr.

ESC Heart Fail. 2019 Aug;6(4):784-792. doi: 10.1002/ehf2.12455. Epub 2019 Jul 3.

6.

Alteration of medical therapy in patients with heart failure relative to change in symptom severity.

Ibrahim NE, Song Y, Cannon CP, Doros G, Russo P, Ponirakis A, Alexanian C, Januzzi JL Jr.

ESC Heart Fail. 2019 Jul 3. doi: 10.1002/ehf2.12480. [Epub ahead of print]

PMID:
31268222
7.

Comparison of novel methods in two-way enriched clinical trial design.

Liu Y, Rybin D, Heeren TC, Doros G.

Stat Med. 2019 Sep 20;38(21):4112-4130. doi: 10.1002/sim.8288. Epub 2019 Jun 30.

PMID:
31256435
8.

Predictors of Mortality in Light Chain Cardiac Amyloidosis with Heart Failure.

Tahir UA, Doros G, Kim JS, Connors LH, Seldin DC, Sam F.

Sci Rep. 2019 Jun 12;9(1):8552. doi: 10.1038/s41598-019-44912-x.

9.

The effect of the duration of preoperative smoking cessation timing on outcomes after elective open abdominal aortic aneurysm repair and lower extremity bypass.

Arinze N, Farber A, Levin SR, Cheng TW, Jones DW, Siracuse CG, Patel VI, Rybin D, Doros G, Siracuse JJ.

J Vasc Surg. 2019 May 27. pii: S0741-5214(19)30366-0. doi: 10.1016/j.jvs.2019.02.028. [Epub ahead of print]

PMID:
31147124
10.

Use of Ventilatory Efficiency Slope as a Marker for Increased Mortality in Wild-Type Transthyretin Cardiac Amyloidosis.

Yunis A, Doros G, Luptak I, Connors LH, Sam F.

Am J Cardiol. 2019 Jul 1;124(1):122-130. doi: 10.1016/j.amjcard.2019.03.035. Epub 2019 Apr 9.

PMID:
31053293
11.

Long term outcome of patients treated on clinical trials of immunomodulatory agents for the treatment of Immunoglobulin light chain (AL) amyloidosis: A pooled analysis.

Sanchorawala V, Doros G, Shelton AC.

Am J Hematol. 2019 Jul;94(7):E194-E196. doi: 10.1002/ajh.25497. Epub 2019 May 3. No abstract available.

PMID:
31020691
12.

National criteria for academic appointment in vascular surgery.

Cheng TW, Farber A, Rajani RR, Jones DW, Flynn D, Rybin D, Doros G, Kalish JA, Meltzer AJ, Siracuse JJ.

J Vasc Surg. 2019 May;69(5):1559-1565. doi: 10.1016/j.jvs.2018.08.178.

PMID:
31010519
13.

Acid-suppressive medications and risk of pneumonia in acute stroke patients: A systematic review and meta-analysis.

Marchina S, Doros G, Modak J, Helenius J, Aycock DM, Kumar S.

J Neurol Sci. 2019 May 15;400:122-128. doi: 10.1016/j.jns.2019.02.041. Epub 2019 Mar 13.

PMID:
30927619
14.

Testosterone Therapy in Men With Hypogonadism Prevents Progression From Prediabetes to Type 2 Diabetes: Eight-Year Data From a Registry Study.

Yassin A, Haider A, Haider KS, Caliber M, Doros G, Saad F, Garvey WT.

Diabetes Care. 2019 Jun;42(6):1104-1111. doi: 10.2337/dc18-2388. Epub 2019 Mar 12.

PMID:
30862651
15.

A commentary on: statistical inference problems in sequential parallel comparison designs.

Schoenfeld DA, Doros G, Fava M.

J Biopharm Stat. 2019 Feb 22:1-4. doi: 10.1080/10543406.2019.1584207. [Epub ahead of print]

PMID:
30794042
16.

Differences in Management of Coronary Artery Disease in Patients With Medicare Advantage vs Traditional Fee-for-Service Medicare Among Cardiology Practices.

Figueroa JF, Blumenthal DM, Feyman Y, Frakt AB, Turchin A, Doros G, Gao Q, Song Y, Joynt Maddox KE.

JAMA Cardiol. 2019 Mar 1;4(3):265-271. doi: 10.1001/jamacardio.2019.0007.

PMID:
30785590
17.

Long-term treatment with testosterone undecanoate injections in men with hypogonadism alleviates erectile dysfunction and reduces risk of major adverse cardiovascular events, prostate cancer, and mortality.

Saad F, Caliber M, Doros G, Haider KS, Haider A.

Aging Male. 2019 Feb 20:1-12. doi: 10.1080/13685538.2019.1575354. [Epub ahead of print]

PMID:
30782054
18.

Mortality Not Correlated With Paclitaxel Exposure: An Independent Patient-Level Meta-Analysis of a Drug-Coated Balloon.

Schneider PA, Laird JR, Doros G, Gao Q, Ansel G, Brodmann M, Micari A, Shishehbor MH, Tepe G, Zeller T.

J Am Coll Cardiol. 2019 May 28;73(20):2550-2563. doi: 10.1016/j.jacc.2019.01.013. Epub 2019 Jan 25. Erratum in: J Am Coll Cardiol. 2019 Feb 28;:.

19.

Design and rationale of a randomized noninferiority trial to evaluate the SurVeil drug-coated balloon in subjects with stenotic lesions of the femoropopliteal artery - the TRANSCEND study.

Elmariah S, Ansel GM, Brodmann M, Doros G, Fuller S, Gray WA, Pinto DS, Rosenfield KA, Mauri L.

Am Heart J. 2019 Mar;209:88-96. doi: 10.1016/j.ahj.2018.12.012. Epub 2018 Dec 28.

PMID:
30685679
20.

Long-term outcome of kidney transplantation in AL amyloidosis.

Angel-Korman A, Stern L, Sarosiek S, Sloan JM, Doros G, Sanchorawala V, Havasi A.

Kidney Int. 2019 Feb;95(2):405-411. doi: 10.1016/j.kint.2018.09.021. Epub 2018 Dec 21.

PMID:
30580886
21.

Adiponectin, leptin and high sensitivity C-reactive protein values in obese children - important markers for metabolic syndrome?

Stroescu RF, Mărginean O, Bizerea T, Gafencu M, Voicu A, Doroș G.

J Pediatr Endocrinol Metab. 2019 Jan 28;32(1):27-31. doi: 10.1515/jpem-2018-0378.

PMID:
30530892
22.

Association of frailty index with perioperative mortality and in-hospital morbidity after elective lower extremity bypass.

Eslami MH, Saadeddin Z, Rybin DV, Doros G, Siracuse JJ, Farber A.

J Vasc Surg. 2019 Mar;69(3):863-874.e1. doi: 10.1016/j.jvs.2018.07.050. Epub 2018 Oct 24.

PMID:
30527215
23.
24.

The asthma Symptom Free Days Questionnaire: how reliable are patient responses?

Yawn BP, Israel E, Wechsler ME, Pace W, Madison S, Manning B, Doros G, Fuhlbrigge A.

J Asthma. 2018 Oct 26:1-9. doi: 10.1080/02770903.2018.1531990. [Epub ahead of print]

PMID:
30365368
25.

Subgroup Analysis Comparing Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Acute Coronary Syndrome Patients.

Roguin A, Kandzari DE, Marcusohn E, Koolen JJ, Doros G, Massaro JM, Garcia-Garcia HM, Bennett J, Gharib EG, Cutlip DE, Waksman R.

Circ Cardiovasc Interv. 2018 Oct;11(10):e007331. doi: 10.1161/CIRCINTERVENTIONS.118.007331.

PMID:
30354631
26.

Development and validation of a survival staging system incorporating BNP in patients with light chain amyloidosis.

Lilleness B, Ruberg FL, Mussinelli R, Doros G, Sanchorawala V.

Blood. 2019 Jan 17;133(3):215-223. doi: 10.1182/blood-2018-06-858951. Epub 2018 Oct 17.

PMID:
30333122
27.

Comparison of one-stage and two-stage upper arm brachiobasilic arteriovenous fistula in the Vascular Quality Initiative.

Tan TW, Siracuse JJ, Brooke BS, Baril DT, Woo K, Rybin D, Doros G, Farber A.

J Vasc Surg. 2019 Apr;69(4):1187-1195.e2. doi: 10.1016/j.jvs.2018.07.049. Epub 2018 Oct 6.

PMID:
30301685
28.

Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin Durable Polymer Everolimus-Eluting Stents.

Kandzari DE, Koolen JJ, Doros G, Massaro JJ, Garcia-Garcia HM, Bennett J, Roguin A, Gharib EG, Cutlip DE, Waksman R; BIOFLOW V Investigators.

J Am Coll Cardiol. 2018 Dec 25;72(25):3287-3297. doi: 10.1016/j.jacc.2018.09.019. Epub 2018 Sep 23.

29.

De novo unbalanced translocation t(15;22)(q26.2;q12) with velo-cardio-facial syndrome: A case report and review of the literature.

Gug C, Huțanu D, Vaida M, Doroş G, Popa C, Stroescu R, Furău G, Furău C, Grigoriță L, Mozos I.

Exp Ther Med. 2018 Oct;16(4):3589-3595. doi: 10.3892/etm.2018.6609. Epub 2018 Aug 16.

30.

Never events after hepatopancreatobiliary operations.

Siracuse JJ, Paracha M, Farber A, Rybin D, Doros G, Tseng J, McAneny D, Sachs T.

Am J Surg. 2018 Dec;216(6):1129-1134. doi: 10.1016/j.amjsurg.2018.06.029. Epub 2018 Jun 30.

PMID:
30146274
31.

Do 5α-Reductase Inhibitors Raise Circulating Serum Testosterone Levels? A Comprehensive Review and Meta-Analysis to Explaining Paradoxical Results.

Traish AM, Krakowsky Y, Doros G, Morgentaler A.

Sex Med Rev. 2019 Jan;7(1):95-114. doi: 10.1016/j.sxmr.2018.06.002. Epub 2018 Aug 8.

PMID:
30098986
32.

Laser balloon ablation for AF: A systematic review and meta-analysis.

Reynolds MR, Zheng Q, Doros G.

J Cardiovasc Electrophysiol. 2018 Oct;29(10):1363-1370. doi: 10.1111/jce.13698. Epub 2018 Aug 23.

PMID:
30016008
33.

Susceptibility to exacerbations in Black adults with asthma.

Grossman NL, Doros GD, Fandino N, Fuhlbrigge AL, Pace WD, Wechsler ME, Yawn BP, Israel E.

J Asthma. 2019 Jul;56(7):704-710. doi: 10.1080/02770903.2018.1486855. Epub 2018 Oct 4.

PMID:
29969928
34.

Patients with end-stage renal disease have poor outcomes after endovascular abdominal aortic aneurysm repair.

Komshian S, Farber A, Patel VI, Goodney PP, Schermerhorn ML, Blazick EA, Jones DW, Rybin D, Doros G, Siracuse JJ.

J Vasc Surg. 2019 Feb;69(2):405-413. doi: 10.1016/j.jvs.2018.04.031. Epub 2018 Jun 23.

PMID:
29945838
35.

Features of atrial fibrillation in wild-type transthyretin cardiac amyloidosis: a systematic review and clinical experience.

Mints YY, Doros G, Berk JL, Connors LH, Ruberg FL.

ESC Heart Fail. 2018 Oct;5(5):772-779. doi: 10.1002/ehf2.12308. Epub 2018 Jun 19.

36.

Predictors of oral anticoagulant non-prescription in patients with atrial fibrillation and elevated stroke risk.

Lubitz SA, Khurshid S, Weng LC, Doros G, Keach JW, Gao Q, Gehi AK, Hsu JC, Reynolds MR, Turakhia MP, Maddox TM.

Am Heart J. 2018 Jun;200:24-31. doi: 10.1016/j.ahj.2018.03.003. Epub 2018 Mar 10.

38.

Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials.

Golwala HB, Cannon CP, Steg PG, Doros G, Qamar A, Ellis SG, Oldgren J, Ten Berg JM, Kimura T, Hohnloser SH, Lip GYH, Bhatt DL.

Eur Heart J. 2018 May 14;39(19):1726-1735a. doi: 10.1093/eurheartj/ehy162.

39.

Routine Use of Ultrasound Guidance in Femoral Arterial Access for Peripheral Vascular Intervention Decreases Groin Hematoma Rates in High-Volume Surgeons.

Inagaki E, Farber A, Siracuse JJ, Mell MW, Rybin DV, Doros G, Kalish J; Vascular Quality Initiative.

Ann Vasc Surg. 2018 Aug;51:1-7. doi: 10.1016/j.avsg.2018.02.008. Epub 2018 Apr 13.

PMID:
29655812
40.

Outcomes of Peripheral Vascular Interventions in Select Patients With Lower Extremity Acute Limb Ischemia.

Inagaki E, Farber A, Kalish JA, Eslami MH, Siracuse JJ, Eberhardt RT, Rybin DV, Doros G, Hamburg NM; Vascular Study Group of New England.

J Am Heart Assoc. 2018 Apr 12;7(8). pii: e004782. doi: 10.1161/JAHA.116.004782.

41.

Improved access to health care in Massachusetts after 2006 Massachusetts Healthcare Reform Law is associated with a significant decrease in mortality among vascular surgery patients.

Eslami MH, Reitz KM, Rybin DV, Doros G, Farber A.

J Vasc Surg. 2018 Oct;68(4):1193-1202.e1. doi: 10.1016/j.jvs.2017.12.066. Epub 2018 Mar 31.

PMID:
29615354
42.

N-Terminal Pro-B-Type Natriuretic Peptide in the Emergency Department: The ICON-RELOADED Study.

Januzzi JL Jr, Chen-Tournoux AA, Christenson RH, Doros G, Hollander JE, Levy PD, Nagurney JT, Nowak RM, Pang PS, Patel D, Peacock WF, Rivers EJ, Walters EL, Gaggin HK; ICON-RELOADED Investigators.

J Am Coll Cardiol. 2018 Mar 20;71(11):1191-1200. doi: 10.1016/j.jacc.2018.01.021.

43.

Bioresorbable polymer drug-eluting stents - Authors' reply.

Kandzari DE, Mauri L, Koolen JJ, Doros G, Waksman R.

Lancet. 2018 Mar 10;391(10124):936-937. doi: 10.1016/S0140-6736(18)30535-X. No abstract available.

PMID:
29536855
44.

Heart rate, beta-blocker use, and outcomes of heart failure with reduced ejection fraction.

Ibrahim NE, Gaggin HK, Turchin A, Patel HK, Song Y, Trebnick A, Doros G, Maya JF, Cannon CP, Januzzi JL.

Eur Heart J Cardiovasc Pharmacother. 2019 Jan 1;5(1):3-11. doi: 10.1093/ehjcvp/pvy011.

PMID:
29490032
45.

Association of Prenatal Ultrasonography and Autism Spectrum Disorder.

Rosman NP, Vassar R, Doros G, DeRosa J, Froman A, DiMauro A, Santiago S, Abbott J.

JAMA Pediatr. 2018 Apr 1;172(4):336-344. doi: 10.1001/jamapediatrics.2017.5634.

46.

Predictive value of the new renal response criteria in AL amyloidosis treated with high dose melphalan and stem cell transplantation.

Havasi A, Doros G, Sanchorawala V.

Am J Hematol. 2018 May;93(5):E129-E132. doi: 10.1002/ajh.25066. Epub 2018 Feb 24. No abstract available.

47.

Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR).

Phull P, Sanchorawala V, Connors LH, Doros G, Ruberg FL, Berk JL, Sarosiek S.

Amyloid. 2018 Mar;25(1):62-67. doi: 10.1080/13506129.2018.1436048. Epub 2018 Feb 9.

48.

Addition or removal of guideline directed medical therapy in ambulatory patients with heart failure with reduced ejection fraction relative to change in symptom severity: An analysis from the PINNACLE (Practice Innovation and Clinical Excellence) Registry®.

Ibrahim NE, Song Y, Cannon CP, Doros G, Trebnick A, Russo P, Ponirakis A, Alexanian C, Januzzi JL Jr.

Int J Cardiol. 2018 Mar 1;254:222-223. doi: 10.1016/j.ijcard.2017.10.096. Epub 2018 Jan 28. No abstract available. Retraction in: Int J Cardiol. 2018 Mar 1;254:R1.

PMID:
29407094
49.

Comparison of access type on perioperative outcomes after endovascular aortic aneurysm repair.

Siracuse JJ, Farber A, Kalish JA, Jones DW, Rybin D, Doros G, Scali ST, Schermerhorn ML; Vascular Quality Initiative.

J Vasc Surg. 2018 Jul;68(1):91-99. doi: 10.1016/j.jvs.2017.10.075. Epub 2018 Jan 17.

PMID:
29342431
50.

Impact of Clopidogrel Therapy on Mortality and Cancer in Patients With Cardiovascular and Cerebrovascular Disease: A Patient-Level Meta-Analysis.

Elmariah S, Doros G, Benavente OR, Bhatt DL, Connolly SJ, Yusuf S, Steinhubl SR, Liu Y, Hsieh WH, Yeh RW, Mauri L.

Circ Cardiovasc Interv. 2018 Jan;11(1):e005795. doi: 10.1161/CIRCINTERVENTIONS.117.005795.

PMID:
29311290

Supplemental Content

Support Center